Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objectives of this trial are to evaluate the efficacy and safety of a dose range of safinamide 50-100 mg p.o. q.a.m., compared to placebo as add-on therapy in subjects with idiopathic Parkinson’s Disease with motor fluctuations, who are receiving a stable dose of levodopa. Evaluate the change from baseline to W24 in daily “on” time (“on” time without dyskinesia plus “on” time with minor dyskinesia) of a dose range of safinamide 50-100 mg p.o. q.a.m., compared to placebo as add-on therapy in subjects with idiopathic Parkinson’s Disease with motor fluctuations, who are receiving a stable dose of levodopa.
Critère d'inclusion
- Ideopathic Parkinson's Disease